Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.005 Å; disorder in main residue; R factor = 0.074; wR factor = 0.254; data-to-parameter ratio = 12.2.
The title compound, C 21 H 18 O 7 , is an important intermediate in the synthesis of 3-(4-hydroxyphenyl)-4-methyl-6-methoxy-7-hydroxycoumarin, which is a nonsteroidal analogue of 2-methoxyestradiol (2-ME). The substituent benzene ring is not in the same plane as the coumarin ring system, with a dihedral angle of 66.88 (10) . There are some weak intermolecular C-HÁ Á ÁO interactions. One carbonyl O atom is disordered over two sites, with occupancies of 0.6 and 0.4. 
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Data collection
Bruker SMART APEX CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1996) T min = 0. Table 1 Hydrogen-bond geometry (Å , ). 4-(7-Acetoxy-6-methoxy-4-methyl-2-oxo-2H-chromen-3-yl)phenyl acetate H. Jiang, P. Xia and Q. Zhang Comment 2-ME, an endogenous metabolite of estrogen, was proved to be a potent antitumor and antiangiogenic compound (Gibanananda et al., 2006) . Currently 2-ME is in phase I-III clinical trials for treating a variety of solid cancers, especially breast cancer, prostate cancer and multiple myeloma (Sutherland et al., 2007) . Based on the structure and the bioactivity of 2-ME, 3-(p-hydroxyphenyl)-4-methyl-6-methoxyl-7-hydroxycoumarin, an non-steroidal analog of 2-ME, was designed, synthesized and evaluated on Human Umbilical Vein Endothelial Cells (HUVEC). The compound showed higher activity and much lower toxicity (EC 50 = 5.69 µM; TI = 45.01) than 2-ME (EC 50 = 8.59 µM; TI = 8.25) in the biological assay. Here we report the crystal structure of 3-(p-acetoxyphenyl)-4-methyl-6-methoxyl-7-acetoxycoumarin, which is an important intermediate in the synthesis of 3-(p-hydroxyphenyl)-4-methyl-6-methoxyl-7-hydroxycoumarin. The molecular structure of (I) is illustrated in Fig.1 . The coumarin ring system (C1-C10) is essentially planar, with a mean deviation of 0.0153 Å from the least-squares plane defined by the ten constituent atoms. The coumarin ring system and the 3-aryl ring make a dihedral angle of 66.88 (10)°. The fact that the of C3-C12 bond [length 1.480 (4) Å] is a single bond also confirms that the coumarin ring system and the 3-substituent are not conjugated. The molecular packing (Fig. 2) is stabilized by weak intermolecular C-H···O hydrogen bonds.
Experimental
A mixture of 1-(2,4-dihydroxyl-5-methoxyphenyl)ethanone (300 mg, 1.65 mmol), 4-hydroxyphenylacetic acid (501 mg, 3.29 mmol), Et 3 N (6 ml) and Ac 2 O (10 ml) was refluxed for 10 h. After cooling, the mixture was poured into 2 N HCl (20 ml) and extracted with acetyl acetate. The organic layer was dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure to give a yellow oil, which was purified via chromatography on silica gel column with petroleum ether/acetone (10:3) as eluent. The title compound was recrystallized from acetyl acetate to give colorless crystals for the single-crystal X-ray diffraction analysis.
Refinement
All H atoms were positioned geometrically and refined using a riding model with C-H = 0.93 Å for aromatic H atoms and 0.96 Å for methyl H atoms, and refined in riding mode with U iso (H) = 1.2 U eq (C) for aromatic H atoms and U iso (H) = 1.5 U eq (C) for methyl H atoms. Figures   Fig. 1 . The molecular structure of (I), with atom labels and 30% probability displacement ellipsoids for non-H atoms. The minor disorder component is not shown. Primary atom site location: structure-invariant direct methods 
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